Company Filing History:
Years Active: 2000
Title: Innovations by Inventor Jennifer Lee Lescallett
Introduction
Jennifer Lee Lescallett is a prominent inventor based in Great Falls, Virginia. She has made significant contributions to genetics, particularly in the study of cancer susceptibility mutations associated with the BRCA1 and BRCA2 genes. With two patents to her name, Lescallett continues to push the boundaries of medical innovation.
Latest Patents
Lescallett's latest patents focus on the identification of new mutations in the BRCA1 and BRCA2 genes. The first patent addresses cancer susceptibility mutations of BRCA1, revealing novel mutations located at specific nucleotide numbers in the gene sequence. This invention includes a process for identifying sequence variations through allele-specific sequence-based assays. These methods provide efficient and accurate detection of mutations in test samples of the BRCA1 gene.
Similarly, her second patent pertains to cancer susceptibility mutations of BRCA2. It identifies new mutations at designated nucleotide numbers within the BRCA2 gene sequence, along with a process for identifying sequence variations using similar allele-specific assays. This invention also facilitates the efficient detection of mutations in test samples of the BRCA2 gene.
Career Highlights
Jennifer Lee Lescallett has been a key figure at Oncormed, Inc., where she applies her expertise in genetics to develop innovative solutions for cancer risk assessment. Her dedication to research and her ability to identify critical genetic mutations have marked her as a leader in her field.
Collaborations
Working alongside esteemed colleagues such as Sheri J Olson and Tammy Lawrence, Lescallett has fostered a collaborative environment that promotes groundbreaking research. These partnerships have significantly contributed to the advancements in understanding cancer susceptibility through genetic research.
Conclusion
Inventor Jennifer Lee Lescallett stands out in her field for her contributions to understanding cancer genetics. Through her innovative patents, she has enhanced the capabilities of genetic testing and played a crucial role in identifying mutations that can influence cancer susceptibility. Her ongoing work at Oncormed, Inc. continues to inspire advancements in medical research and innovation.